Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia

Cell Growth and Differentiation

Volumn 12, Issue 6, 2001, Pages 285-295

  Said, T K ^a   Moraes, R C B ^a   Singh, U ^a   Kittrell, F S ^a   Medina, D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN D2; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; ESTROGEN; HYPOPHYSIS HORMONE; PROGESTERONE; PROTEIN P16; PROTEIN P21; PROTEIN P27;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST DEVELOPMENT; BREAST TUMOR; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; HORMONAL REGULATION; HORMONE ACTION; HYPERPLASIA; MITOGENESIS; MORPHOLOGY; MOUSE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR UPREGULATION;

ANIMALS; BREAST; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CYCLIN D1; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; EPITHELIAL CELLS; FEMALE; HORMONES; MICE; MICE, INBRED BALB C; OVARIECTOMY; PRECANCEROUS CONDITIONS; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0034925929     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Mammalian G1 cyclins
2. Mammalian G1 cyclins
3. K-ras modulates the cell cycle via both positive and negative regulatory pathways
4. Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells
5. D-type cyclins
6. Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts
7. Cyclins, cyclin-dependent kinases and differentiation
8. Differential expression of proteins regulating cell cycle progression in growth vs. differentiation
9. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
10. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development
11. Cyclin D1 provides a link between development and oncogenesis in the retina and breast
12. Growth factor, steroid, and steroid antagonists regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression
13. Expression and amplification of cyclin genes in human breast cancer
14. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast
15. Cyclin gene amplification and overexpression in breast and ovarian cancers: Evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors
16. Role of the cyclin-dependent kinase inhibitors in the development of cancer
17. Cyclin and cancer. Cyclin D and CDK inhibitors come of age
18. Cell-cycle regulators and cancer
19. Joining the complex: Cyclin dependent kinase inhibitory proteins and the cell cycle
20. Inhibitors of mammalian G1 cyclin-dependent kinases
21. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/cdk4
22. Growth suppression by p18, a p161NK4/ MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function
23. p15/INK4B is a potential effector of TGF-β-induced cell cycle arrest
24. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6
25. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16INK4
26. WAF1, a potential mediator of p53 tumor suppression
27. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
28. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
29. p21 is a universal inhibitor of cyclin kinases
30. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
31. Cloning of p27kipl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
32. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21
33. Cloning of p57/kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distraction
34. p57/Kip2, a structurally distinct member of the p21/CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene
35. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2
36. Functional interaction of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
37. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases
38. The regulation of E2F by pRb-family proteins
39. Toward an understanding of the functional complexity of the E2F and retinoblastoma families
40. The mammary gland: A model for development
41. Regulation of mammary gland development by tissue interaction
42. Progesterone, in addition to estrogen, induces cyclin D1 expression in the murine mammary epithelial cell, in vivo
43. The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but nor progesterone
44. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function
45. INK4b genes
46. Kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
47. Control of mammary gland development
48. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution
49. INK4a alteration in murine primary T-cell lymphomas
50. Tumor spectrum in ARF-deficient mice
51. Immortalization phenotype dissociated from the preneoplastic phenotype in mouse mammary epithelial outgrowths in vivo
52. Regulation of the human cell cycle by the cdk2 protein kinase
53. Distinct roles for cyclin-dependent kinases in cell cycle control
54. Kip1 contributes to growth and differentiation of osteoblasts
55. Up-regulation of p27kip1, p21WAF1/Cip1 and p16Ink4a is associated with, but not sufficient for, induction of squamous differentiation
56. Tumor suppressor proteins as regulators of cell differentiation
57. kip1
58. Kip1
59. Prognostic role of p27kip1 and apoptosis in human breast cancer
60. Decreased levels of the cell cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
61. Tumor suppressor genes and their roles in breast cancer
62. p21-containing cyclin kinases exit in both active and inactive states
63. New functional activities for the p21 family of CDK inhibitors
64. KIP1 expression indicates that steroid receptor-positive cells are a non-proliferating, differentiated subpopulation of the normal human breast epithelium
65. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis
66. Recent developments in the molecular genetic understanding of breast cancer
67. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle
68. Immunohistochemistry of cyclin D1 in human breast cancer
69. Cyclin D2 activates cdk2 in preference to cdk4 in human breast epithelial cells
70. Enhancement of tumorigenicity with morphological progression in BALB/c preneoplastic outgrowth line
71. Preneoplasia in mammary tumorigenesis
72. Immortal, non-tumorigenic mouse mammary outgrowths express high levels of cyclin B1 and activation of cyclin B1/cdc2 kinase
73. Establishment of mouse mammary cell lines
74. Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to cdk4